Series date: 
01/07/2021 - 4:00pm EST to 12/31/2024 - 5:00pm EST

Sessions

Sessionsort ascending Date
Use of therapeutic plasma exchange in heparin-induced thrombocytopenia: A population-based study 01/27/2021 - 4:00pm to 5:00pm EST
Use of therapeutic plasma exchange as adjunctive therapy in the treatment of coronavirus disease 02/24/2021 - 4:00pm to 5:00pm EST
Use of plasma exchange for pediatric multi-inflammatory syndrome in children (MIS-C) 12/22/2021 - 4:00pm to 5:00pm EST
Therapeutic plasma exchange in patients with sepsis: Secondary analysis of a cluster-randomized controlled trial 03/13/2024 - 3:30pm to 4:30pm EDT
Therapeutic Options for Recurrence of FSGS in the Renal Allograft 04/10/2024 - 3:30pm to 4:30pm EDT
The ADAPT trial for myasthenia gravis 05/31/2023 - 3:30pm to 4:03pm EDT
Successful treatment of pure red cell aplasia using therapeutic plasma exchange after ABO-incompatible hematopoietic stem cell transplant 02/22/2023 - 3:30pm to 4:30pm EST
Stem cell mobilizating effect of heparin in patients undergoing autologous stem cell transplantation 11/15/2023 - 3:30pm to 4:30pm EST
Safety of Therapeutic Apheresis in Children and Adolescents 08/10/2022 - 3:30pm to 4:30pm EDT
Safety and Tolerability of Solvent/Detergent-Treated Plasma for Pediatric Patients Requiring Therapeutic Plasma Exchange 10/19/2022 - 3:30pm to 4:30pm EDT

Pages